Physician profile
James C Meade
NPI 1316054299
$2,100.74
in general payments reported to CMS, 2019-2025
19 companies · $1,007 in 2025
The $1,007 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $220 · 2021: $208 · 2022: $148 · 2023: $195 · 2024: $84.63 · 2025: $1,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998 · Travel and Lodging: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $998.22 |
| Travel and Lodging | $288.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $925.77 | 2021-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Paratek Pharmaceuticals, INC. | $274.10 | 2020-2025 | Nuzyra |
| Smith+Nephew, INC. | $208.54 | 2019-2021 | |
| Abbott Laboratories | $113.95 | 2019-2023 | Diamondback Peripheral |
| Organogenesis INC. | $100.90 | 2019-2024 | Puraply |
| Misonix INC | $80.55 | 2020-2021 | |
| Cardiovascular Systems INC. | $66.70 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $55.35 | 2022 | |
| Horizon Therapeutics Plc | $55.11 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $44.66 | 2022-2023 | Jublia |
| Orthofix Medical, INC. | $35.32 | 2019-2024 | Physio-Stim |
| Heron Therapeutics, INC. | $25.85 | 2022 | |
| Osteomed LLC | $22.61 | 2021 | |
| Zimmer Biomet Holdings, INC. | $19.67 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $18.35 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $14.58 | 2020 | |
| Hartmann USA, INC. | $13.38 | 2020 | |
| Treace Medical Concepts, INC. | $13.31 | 2023 | |
| Nabriva Therapeutics, Plc | $12.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Meade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.